Projects per year
Personal profile
Education
- 2010 PhD, Department of Clinical, Social and Administrative Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA
Experience
- 2010/8-2011/7 Postdotoral research fellow, College of Pharmacy, University of Michigan, Ann Arbor, MI University of Michigan, Michigan, USA
- 2011/08 ~ 2012/07 Assistant Professor, Department of Pharmacy Practice, College of Pharmacy, South Dakota State University, USA
- 2012/08 ~ 2017/01 Assistant Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences & Department of Pharmacy, College of Medicine, National Cheng Kung University
- 2017/02~ present Associate Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences & Department of Pharmacy, College of Medicine, National Cheng Kung University
Research Interests
- Pharmacoeconomics
- Patient-reported outcomes
- Pharmacoepidemiology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Huang-Tz Ou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 8 Finished
-
-
-
建構創新糖尿病疾病預測與成本效益模型，以提供台灣於疾病照護與健保政策之參酌：應用機器學習與模型方法於臨床大數據之研究
19-08-01 → 20-07-31
Project: Research project
-
-
-
Association of retinopathy severity with cardiovascular and renal outcomes in patients with type 1 diabetes: a multi-state modeling analysis
Wang, W. M., Ou, H. T., Wen, M. J., Su, P. F., Yang, C. Y., Kuo, T. H., Wang, M. C. & Lin, W. H., 2022 Dec, In: Scientific reports. 12, 1, 4177.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review
Yang, C. T., Peng, Z. Y., Chen, Y. C., Ou, H. T. & Kuo, S., 2022 Mar 7, In: Frontiers in Endocrinology. 13, 836365.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus) -
Co-Administration of Clomiphene Citrate and Letrozole in Mild Ovarian Stimulation Versus Conventional Controlled Ovarian Stimulation Among POSEIDON Group 4 Patients
Lin, H. T., Wu, M. H., Tsai, L. C., Chen, T. S. & Ou, H. T., 2022 Jan 14, In: Frontiers in Endocrinology. 12, 780392.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Continuity and Completeness of Electronic Health Record Data for Patients Treated With Oral Hypoglycemic Agents: Findings From Healthcare Delivery Systems in Taiwan
Hsu, C. N., Huang, K., Lin, F. J., Ou, H. T., Huang, L. Y., Kuo, H. C., Wang, C. C. & Toh, S., 2022 Apr 4, In: Frontiers in Pharmacology. 13, 845949.Research output: Contribution to journal › Article › peer-review
Open Access -
Cost-effectiveness of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors among patients with type 2 diabetes with and without established cardiovascular diseases: A model-based simulation analysis using 10-year real-world data and targeted literature review
Peng, Z. Y., Yang, C. T., Ou, H. T. & Kuo, S., 2022 Jul, In: Diabetes, Obesity and Metabolism. 24, 7, p. 1328-1337 10 p.Research output: Contribution to journal › Article › peer-review